Bruce A. Sullenger
Affiliations: | Molecular Genetics and Microbiology | Duke University, Durham, NC |
Area:
Molecular Biology, Cell Biology, BiochemistryGoogle:
"Bruce Sullenger"Children
Sign in to add trainee| Ning Lan | grad student | 2000 | Duke |
| Meredith B. Long | grad student | 2001 | Duke |
| Alice K. Tanner | grad student | 2004 | Duke |
| Shahid M. Nimjee | grad student | 2005 | Duke |
| Kristi D. Viles | grad student | 2006 | Duke |
| Monique N. Kierlin-Duncan | grad student | 2007 | Duke |
| Claudia M. Dollins | grad student | 2008 | Duke |
| Sabah Oney | grad student | 2008 | Duke |
| Charlene M. Blake | grad student | 2009 | Duke |
| Kristin M. Bompiani | grad student | 2012 | Duke |
| Jonathan W. Kotula | grad student | 2012 | Duke |
| Elizabeth D. Pratico | post-doc | Duke (Chemistry Tree) | |
| Partha Ray | post-doc | Duke (Chemistry Tree) | |
| Jacoba Slagter-Jager | post-doc | Duke | |
| Johannes Urban | post-doc | Duke | |
| Kristi D. Viles | post-doc | Duke | |
| Jialiang Wayg | post-doc | Duke |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gray BP, Kelly L, Steen-Burrell KA, et al. (2023) Rapid molecular imaging of active thrombi using aptamer-antidote probes. Molecular Therapy. Nucleic Acids. 31: 440-451 |
| Shea SM, Thomas KA, Rassam RMG, et al. (2022) Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals (Basel, Switzerland). 15 |
| Corey KM, Olson LB, Naqvi IA, et al. (2022) Exposure and Outcome in practice: a retrospective cohort study between fibrinolytic suppression and hypercoagulability, the severity of hypoxemia, and mortality in COVID-19 patients. Anesthesiology |
| Zakeri A, Jadhav AP, Sullenger BA, et al. (2020) Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. Journal of Neurointerventional Surgery |
| Sullenger BA. (2020) RGEN Editing of RNA and DNA: The Long and Winding Road from Catalytic RNAs to CRISPR to the Clinic. Cell. 181: 955-960 |
| Eteshola E, Landa K, Hwang ES, et al. (2020) Blocking pro-invasive signaling and inflammatory activation in triple-negative breast cancer with nucleic-acid scavengers (NASs). Journal of Clinical Oncology. 38: e13096-e13096 |
| Nair S, Holl E, Landa K, et al. (2020) Abstract P3-01-03: Modulating inflammation with nucleic acid scavengers to prevent breast cancer metastasis Cancer Research. 80 |
| Gray BP, Requena MD, Nichols MD, et al. (2019) Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State. Cell Chemical Biology |
| Nimjee SM, Sullenger BA. (2019) Therapeutic Aptamers: Evolving to Find Their Clinical Niche. Current Medicinal Chemistry |
| Nimjee SM, Dornbos D, Pitoc GA, et al. (2019) Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels. Molecular Therapy : the Journal of the American Society of Gene Therapy |